Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2008, Article ID 936906, 9 pages
http://dx.doi.org/10.1155/2008/936906
Review Article

The Development of INT131 as a Selective PPAR 饾湼 Modulator: Approach to a Safer Insulin Sensitizer

1InteKrin Therapeutics, Inc., 4300 El Camino Real, Suite 201, Los Altos, CA 94022, USA
2Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA

Received 18 March 2008; Accepted 14 June 2008

Academic Editor: Anne Miller

Copyright © 2008 Linda S. Higgins and Christos S. Mantzoros. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [44 citations]

The following is the list of published articles that have cited the current article.

  • Yang-liang Ye, Zhou Zhou, Han-jun Zou, Yu Shen, Ti-fei Xu, Jing Tang, Hua-zhong Yin, Min-li Chen, Ying Leng, and Jian-hua Shen, “Discovery of novel dual functional agent as PPARγ agonist and 11β-HSD1 inhibitor for the treatment of diabetes,” Bioorganic & Medicinal Chemistry, vol. 17, no. 15, pp. 5722–5732, 2009. View at PublisherView at Google Scholar
  • Cyrus DeSouza, and Vivian Fonseca, “OPINION Therapeutic targets to reduce cardiovascular disease in type 2 diabetes,” Nature Reviews Drug Discovery, vol. 8, no. 5, pp. 361–367, 2009. View at PublisherView at Google Scholar
  • Alykhan Motani, Zhulun Wang, Jennifer Weiszmann, Lawrence R. McGee, Gary Lee, Qingxiang Liu, Jocelyn Staunton, Zexu Fang, Helen Fuentes, Michelle Lindstrom, Jinsong Liu, Donna H.T. Biermann, Juan Jaen, Nigel P.C. Walker, R. Marc Learned, Jin-Long Chen, and Yang Li, “INT131: A Selective Modulator of PPARγ,” Journal of Molecular Biology, vol. 386, no. 5, pp. 1301–1311, 2009. View at PublisherView at Google Scholar
  • Donald J. Abraham, Peter T.W. Cheng, Ellen Kick, and Ranjan MukherjeeBurger's Medicinal Chemistry and Drug Discovery, 2010. View at PublisherView at Google Scholar
  • Fiona Simpson, and Jonathan P. Whitehead, “Adiponectin-It's all about the modifications,” International Journal of Biochemistry & Cell Biology, vol. 42, no. 6, pp. 785–788, 2010. View at PublisherView at Google Scholar
  • Lalit S Doshi, Manoja Kumar Brahma, Umakant A Bahirat, Amol V Dixit, and Kumar VS Nemmani, “Discovery and development of selective PPARγ modulators as safe and effective antidiabetic agents,” Expert Opinion on Investigational Drugs, vol. 19, no. 4, pp. 489–512, 2010. View at PublisherView at Google Scholar
  • Hee Yeon Won, Hyun Jung Min, Jin Hee Ahn, Sung-Eun Yoo, Myung Ae Bae, Jeong-Ho Hong, and Eun Sook Hwang, “Anti-allergic function and regulatory mechanisms of KR62980 in allergen-induced airway inflammation,” Biochemical Pharmacology, vol. 79, no. 6, pp. 888–896, 2010. View at PublisherView at Google Scholar
  • F. J. Rose, J. Webster, J. B. Barry, L. K. Phillips, A. A. Richards, and J. P. Whitehead, “Synergistic effects of ascorbic acid and thiazolidinedione on secretion of high molecular weight adiponectin from human adipocytes,” Diabetes Obesity & Metabolism, vol. 12, no. 12, pp. 1084–1089, 2010. View at PublisherView at Google Scholar
  • Tatsuo Kobayashi, Yuko Akiyama, Nobuteru Akiyama, Hideaki Katoh, Sachiko Yamamoto, Kenzo Funatsuki, Toru Yanagimoto, Mitsuru Notoya, Kenji Asakura, Toshihiro Shinosaki, and Kohji Hanasaki, “Irbesartan enhances GLUT4 translocation and glucose transport in skeletal muscle cells,” European Journal Of Pharmacology, vol. 649, no. 1-3, pp. 23–28, 2010. View at PublisherView at Google Scholar
  • George L. Blackburn, “From bench to bedside: novel mechanisms and therapeutic advances through the development of selective peroxisome proliferator-activated receptor gamma modulators,” American Journal Of Clinical Nutrition, vol. 91, no. 1, pp. 251S–253S, 2010. View at PublisherView at Google Scholar
  • Florencia Ziemke, and Christos S. Mantzoros, “Adiponectin in insulin resistance: lessons from translational research,” American Journal of Clinical Nutrition, vol. 91, no. 1, pp. 258S–261S, 2010. View at PublisherView at Google Scholar
  • Linda Slanec Higgins, and Alex M. DePaoli, “Selective peroxisome proliferator-activated receptor gamma (PPAR gamma) modulation as a strategy for safer therapeutic PPAR gamma activation,” American Journal Of Clinical Nutrition, vol. 91, no. 1, pp. 267S–272S, 2010. View at PublisherView at Google Scholar
  • Kenji Wakabayashi, Shinko Hayashi, Yumi Matsui, Takuo Matsumoto, Akihiro Furukawa, Masanori Kuroha, Naomi Tanaka, Tomoko Inaba, Shoichi Kanda, Jun Tanaka, Ryo Okuyama, Satoko Wakimoto, Tsuneaki Ogata, Kazushi Araki, and Jun Ohsumi, “Pharmacology and in vitro profiling of a novel peroxisome proliferator-activated receptor γ ligand, cerco-A,” Biological and Pharmaceutical Bulletin, vol. 34, no. 7, pp. 1094–1104, 2011. View at PublisherView at Google Scholar
  • Fredrick L. Dunn, Linda S. Higgins, Jill Fredrickson, and Alex M. DePaoli, “Selective modulation of PPAR gamma activity can lower plasma glucose without typical thiazolidinedione side-effects in patients with Type 2 diabetes,” Journal Of Diabetes And Its Complications, vol. 25, no. 3, pp. 151–158, 2011. View at PublisherView at Google Scholar
  • Rasmus K. Petersen, Kathrine B. Christensen, Andreana N. Assimopoulou, Xavier Frette, Vassilios P. Papageorgiou, Karsten Kristiansen, and Irene Kouskoumvekaki, “Pharmacophore-driven identification of PPAR gamma agonists from natural sources,” Journal Of Computer-Aided Molecular Design, vol. 25, no. 2, pp. 107–116, 2011. View at PublisherView at Google Scholar
  • Amanda Janesick, and Bruce Blumberg, “Minireview: PPARγ as the target of obesogens,” The Journal of Steroid Biochemistry and Molecular Biology, vol. 127, no. 1-2, pp. 4–8, 2011. View at PublisherView at Google Scholar
  • Mi-Kyung Kim, Yu Na Chae, Song-hyen Choi, Ho Sang Moon, Moon-Ho Son, Myung-Ho Bae, Hyun-ho Choi, Youn Hur, Eunkyung Kim, Yoo Hoi Park, Chan Sun Park, Jae Gyu Kim, Joong In Lim, and Chang Yell Shin, “PAM-1616, a selective peroxisome proliferator-activated receptor γ modulator with preserved anti-diabetic efficacy and reduced adverse effects,” European Journal of Pharmacology, vol. 650, no. 2-3, pp. 673–681, 2011. View at PublisherView at Google Scholar
  • Maria Dalamaga, Kalliope N. Diakopoulos, and Christos S. Mantzoros, “The Role of Adiponectin in Cancer: A Review of Current Evidence,” Endocrine Reviews, vol. 33, no. 4, pp. 547–594, 2012. View at PublisherView at Google Scholar
  • Bertrand Cariou, Bernard Charbonnel, and Bart Staels, “Thiazolidinediones and PPARγ agonists: time for a reassessment,” Trends in Endocrinology & Metabolism, vol. 23, no. 5, pp. 205–215, 2012. View at PublisherView at Google Scholar
  • Dae Ho Lee, Hu Huang, Kangduk Choi, Christos Mantzoros, and Young-Bum Kim, “Selective PPAR gamma modulator INT131 normalizes insulin signaling defects and improves bone mass in diet-induced obese mice,” American Journal Of Physiology-Endocrinology And Metabolism, vol. 302, no. 5, pp. E552–E560, 2012. View at PublisherView at Google Scholar
  • Thomas Cuny, Bruno Guerci, and Bertrand Cariou, “New avenues for the pharmacological management of type 2 diabetes: An update,” Annales d'Endocrinologie, vol. 73, no. 5, pp. 459–468, 2012. View at PublisherView at Google Scholar
  • B. K. He, Z. Q. Ning, Z. B. Li, S. Shan, D. S. Pan, B. C. B. Ko, P. P. Li, Z. F. Shen, G. F. Dou, B. L. Zhang, X. P. Lu, and Y. Gao, “In Vitro and In Vivo Characterizations of Chiglitazar, a Newly Identified PPAR Pan-Agonist,” PPAR Research, vol. 2012, pp. 1–13, 2012. View at PublisherView at Google Scholar
  • Gene P Ables, “Update on pparγ and nonalcoholic Fatty liver disease.,” PPAR research, vol. 2012, pp. 912351, 2012. View at PublisherView at Google Scholar
  • H. Sadie-Van Gijsen, F.S. Hough, and W.F. Ferris, “Determinants of bone marrow adiposity: The modulation of peroxisome proliferator-activated receptor-γ2 activity as a central mechanism,” Bone, 2013. View at PublisherView at Google Scholar
  • Irene Kouskoumvekaki, Rasmus K. Petersen, Filip Fratev, Olivier Taboureau, Thomas E. Nielsen, Tudor I. Oprea, Si B. Sonne, Esben N. Flindt, Svava Osk Jonsdottir, and Karsten Kristiansen, “Discovery of a Novel Selective PPAR gamma Ligand with Partial Agonist Binding Properties by Integrated in Silico/in Vitro Work Flow,” Journal Of Chemical Information And Modeling, vol. 53, no. 4, pp. 923–937, 2013. View at PublisherView at Google Scholar
  • Joshua P. Taygerly, Lawrence R. McGee, Steven M. Rubenstein, Jonathan B. Houze, Timothy D. Cushing, Yang Li, Alykhan Motani, Jin-Long Chen, Walter Frankmoelle, Guosen Ye, Marc R. Learned, Juan Jaen, Shichang Miao, Pieter B. Timmermans, Martin Thoolen, Patrick Kearney, John Flygare, Holger Beckmann, Jennifer Weiszmann, Michelle Lindstrom, Nigel Walker, Jinsong Liu, Donna Biermann, Zhulun Wang, Atsushi Hagiwara, Tetsuya Iida, Hisateru Aramaki, Yuki Kitao, Hisashi Shinkai, Noboru Furukawa, Jun Nishiu, and Motonao Nakamura, “Discovery of INT131: A selective PPARγ modulator that enhances insulin sensitivity,” Bioorganic & Medicinal Chemistry, vol. 21, no. 4, pp. 979–992, 2013. View at PublisherView at Google Scholar
  • Maria Dalamaga, Konstantinos Karmaniolas, John Chamberland, Athina Nikolaidou, Antigoni Lekka, Amalia Dionyssiou-Asteriou, and Christos S. Mantzoros, “Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome,” Metabolism, 2013. View at PublisherView at Google Scholar
  • Wei Wei, and Yihong Wan, “Regulation of Bone Resorption by PPARγ,” Translational Endocrinology of Bone, pp. 103–122, 2013. View at PublisherView at Google Scholar
  • Alex M. DePaoli, Linda S. Higgins, Robert R. Henry, Christos Mantzoros, and Fredrick L. Dunn, “Can a Selective PPAR gamma Modulator Improve Glycemic Control in Patients With Type 2 Diabetes With Fewer Side Effects Compared With Pioglitazone?,” Diabetes Care, vol. 37, no. 7, pp. 1918–1923, 2014. View at PublisherView at Google Scholar
  • Ichiro Takada, and Makoto Makishima, “PPARγ ligands and their therapeutic applications: a patent review (2008 – 2014),” Expert Opinion on Therapeutic Patents, pp. 1–17, 2014. View at PublisherView at Google Scholar
  • Mahmoud Mansour, “The Roles of Peroxisome Proliferator-Activated Receptors in the Metabolic Syndrome,” Glucose Homeostatis and the Pathogenesis of Diabetes Mellitus, vol. 121, pp. 217–266, 2014. View at PublisherView at Google Scholar
  • Alice J. Kroker, and John B. Bruning, “ Review of the Structural and Dynamic Mechanisms of PPAR γ Partial Agonism ,” PPAR Research, vol. 2015, pp. 1–15, 2015. View at PublisherView at Google Scholar
  • Jose Antonio Encinar, Gregorio Fernandez-Ballester, Vicente Galiano-Ibarra, and Vicente Micol, “In silico approach for the discovery of new PPAR gamma modulators among plant-derived polyphenols,” Drug Design Development And Therapy, vol. 9, pp. 5877–5895, 2015. View at PublisherView at Google Scholar
  • Stergios A. Polyzos, Elisabetta Bugianesi, Jannis Kountouras, and Christos S. Mantzoros, “Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPARγ agonists,” Metabolism, 2016. View at PublisherView at Google Scholar
  • Gesthimani Mintziori, and Stergios A. Polyzos, “Emerging and future therapies for nonalcoholic steatohepatitis in adults,” Expert Opinion on Pharmacotherapy, pp. 1–10, 2016. View at PublisherView at Google Scholar
  • Javier Díaz-Alonso, Juan Paraíso-Luna, Carmen Navarrete, Carmen del Río, Irene Cantarero, Belén Palomares, José Aguareles, Javier Fernández-Ruiz, María Luz Bellido, Federica Pollastro, Giovanni Appendino, Marco A. Calzado, Ismael Galve-Roperh, and Eduardo Muñoz, “VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease,” Scientific Reports, vol. 6, pp. 29789, 2016. View at PublisherView at Google Scholar
  • Xiujing Feng, Dan Weng, Feifei Zhou, Young D. Owen, Haohan Qin, Jingfa Zhao, WenYu, Yahong Huang, Jiajia Chen, Haijian Fu, Nanfei Yang, Dianhua Chen, Jianxin Li, Renxiang Tan, and Pingping Shen, “Activation of PPARγ by a Natural Flavonoid Modulator, Apigenin Ameliorates Obesity-Related Inflammation Via Regulation of Macrophage Polarization,” EBioMedicine, 2016. View at PublisherView at Google Scholar
  • Stergios A. Polyzos, and Christos S. Mantzoros, “Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review,” Metabolism, 2016. View at PublisherView at Google Scholar
  • Lavinia Woodward, Ioannis Akoumianakis, and Charalambos Antoniades, “Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease,” British Journal of Pharmacology, 2016. View at PublisherView at Google Scholar
  • Jagriti Upadhyay, Stergios A. Polyzos, Nikolaos Perakakis, Bindiya Thakkar, Stavroula A. Paschou, Niki Katsiki, Patricia Underwood, Kyung-Hee Park, Jochen Seufert, Eun Seok Kang, Elliot Sternthal, Asterios Karagiannis, and Christos S. Mantzoros, “Pharmacotherapy of Type 2 Diabetes: An Update,” Metabolism, 2017. View at PublisherView at Google Scholar
  • Niki Katsiki, Christos Mantzoros, and Dimitri P. Mikhailidis, “Adiponectin, lipids and atherosclerosis,” Current Opinion in Lipidology, vol. 28, no. 4, pp. 347–354, 2017. View at PublisherView at Google Scholar
  • Rebecca L. Frkic, Yuanjun He, Beatriz B. Rodriguez, Mi Ra Chang, Dana Kuruvilla, Anthony Ciesla, Andrew D. Abell, Theodore M. Kamenecka, Patrick R. Griffin, and John B. Bruning, “ Structure–Activity Relationship of 2,4-Dichloro- N -(3,5-dichloro-4-(quinolin-3-yloxy)phenyl)benzenesulfonamide (INT131) Analogs for PPARγ-Targeted Antidiabetics ,” Journal of Medicinal Chemistry, 2017. View at PublisherView at Google Scholar
  • Amol Ranjan, and Suraiya A. Ansari, “Therapeutic potential of Mediator complex subunits in metabolic diseases,” Biochimie, 2017. View at PublisherView at Google Scholar
  • De-Si Pan, Wei Wang, Nan-Song Liu, Qian-Jiao Yang, Kun Zhang, Jing-Zhong Zhu, Song Shan, Zhi-Bin Li, Zhi-Qiang Ning, Laiqiang Huang, and Xian-Ping Lu, “ Chiglitazar Preferentially Regulates Gene Expression via Configuration-Restricted Binding and Phosphorylation Inhibition of PPAR γ ,” PPAR Research, vol. 2017, pp. 1–16, 2017. View at PublisherView at Google Scholar